8chan/8kun QResearch Posts (4)
#4083534 at 2018-11-30 09:51:52 (UTC+1)
Q Research General #5197: Questions Reveal Answers Edition
>>4083145
>>4083488 >>4083497
>>4083151 >>4083173 >>4083177
>>4083219 >>4083313 >>4083464
https://www.google.com/maps/contrib/107315767592708611372/photos/@29.5870415,107.2568487,2083258m/data=!3m1!1e3!4m3!8m2!3m1!1e1
https://www.google.com/maps/contrib/107315767592708611372/photos/@29.5870415,107.2568487,6.03z/data=!4m3!8m2!3m1!1e1
David Hung, see Taiwan also
https://www.google.com/maps/contrib/107315767592708611372/reviews/@27.078592,108.8062299,1303284m/data=!3m1!1e3!4m3!8m2!3m1!1e1
#376641 at 2018-02-14 22:32:12 (UTC+1)
Q Research General #463: The Truth Is Like A LION, Prime Number Edition
CEOs stepping down:
- Paradox, CEO Fredrik Wester
- Axovant, CEO David Hung, COO Marion McCourt
- Blue Cross, CEO Michael Guyette
#361718 at 2018-02-13 10:10:15 (UTC+1)
Q Research General #445: Emergancy Bake Edition
https:// mobile.nytimes.com/reuters/2018/02/12/business/12reuters-axovant-sciences-moves-ceo.html?referer=https:// duckduckgo.com/
By Reuters
Feb. 12, 2018
(Reuters) - Axovant Sciences Ltd's shares sank 20 percent to an all-time low on Monday after Chief Executive David Hung resigned following 10 months at the biotech firm, during which its lead drug candidate failed two key trials.
Axovant Chief Operating Officer Marion McCourt and three directors on the company's board also stepped down.
The departures come after Axovant stopped developing its lead drug, intepirdine, following the failure of two trials testing it as a treatment for Alzheimer's disease and dementia.
#350050 at 2018-02-12 14:58:27 (UTC+1)
Q Research General #430: ABRAHAM LINCOLNS BIRTHDAY Edition
More CEO Resignations:
China-Related
https:// www. wsj.com/articles/zz-capital-internationals-ceo-resigns-1518291999
Pharmaceutical Related
https:// www. reuters.com/article/axovant-sciences-moves-ceo/update-1-axovant-sciences-ceo-David-Hung-resigns-shares-tumble-idUSL4N1Q243C
Canada
http:// www. gulfnews.ca/news/local/central-health-ceo-resigns-185319/